Lindbrook Capital, LLC
- SEC CIK
- 0001767045
- Latest filing
- May 5, 2025
KLRS holding history
Kalaris Therapeutics, Inc. in every 13F filed by Lindbrook Capital, LLC, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.
KLRS overviewAll 13F holders of KLRSFull Q1 2025 holdings
- Shares (Q3 2023)
- 0
- Sold out in Q3 2023
- Value
- $0
- % of portfolio
- 0.0%
- Quarters held
- 4
- Since Q1 2022
| Quarter | Shares | Value | % of portfolio | Share change | Action | All holders |
|---|---|---|---|---|---|---|
| Q3 2023 | 0 | $0 | 0.0% | −639−100.0% | Sold out | Holders |
| Q2 2023 | 639 | $2.17K | <0.1% | +269+72.7% | Added | Holders |
| Q1 2023 | 370 | $1.46K | <0.1% | +370 | New | Holders |
| Q4 2022 | 0 | $0 | 0.0% | −387−100.0% | Sold out | Holders |
| Q3 2022 | 387 | $3.00K | <0.1% | +387 | New | Holders |
| Q2 2022 | 0 | $0 | 0.0% | −268−100.0% | Sold out | Holders |
| Q1 2022 | 268 | $2.00K | <0.1% | +268 | New | Holders |